Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,335 | -2,774 | -335 | -319 | 548 |
| Depreciation Amortization | 2,246 | 1,663 | 1,088 | 528 | 1,627 |
| Accounts receivable | 1,308 | 1,377 | 434 | 158 | -2,818 |
| Accounts payable and accrued liabilities | 2,465 | 1,430 | 1,737 | -331 | 974 |
| Other Working Capital | 4,243 | 4,219 | 1,341 | -879 | 2,336 |
| Other Operating Activity | -955 | -1,251 | -1,174 | 648 | 3,830 |
| Operating Cash Flow | $3,972 | $4,664 | $3,091 | $-195 | $6,497 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,872 | -2,112 | -1,358 | -754 | -2,384 |
| Investing Cash Flow | $-2,872 | $-2,112 | $-1,358 | $-754 | $-2,384 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 85 | 86 | 86 | N/A | 207 |
| Common Stock Repurchased | -74 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $11 | $86 | $86 | $N/A | $207 |
| Beginning Cash Position | 9,007 | 9,007 | 9,007 | 9,007 | 4,687 |
| End Cash Position | 10,118 | 11,645 | 10,826 | 8,058 | 9,007 |
| Net Cash Flow | $1,111 | $2,638 | $1,819 | $-949 | $4,320 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,972 | 4,664 | 3,091 | -195 | 6,497 |
| Capital Expenditure | -2,872 | -2,112 | -1,358 | -754 | -2,384 |
| Free Cash Flow | 1,100 | 2,552 | 1,733 | -949 | 4,113 |